First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months) and Keytruda® + chemotherapy (12.3 months) in patients ...

Nanobiotix S.A. stock surges on promising cancer trial results and major partnership. Click for more on NBTX stock and why ...

Recent treatment innovations for lung cancer and melanoma have improved survival overall but also increased disparities in survival according to income, researchers found.

The latest announcement is out from PDS Biotechnology ( (PDSB) ).

Next-Generation Multi-Antigen COVID-19 Vaccine Demonstrates Differentiated Immune Responses in Immunocompromised Patients ...

Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been ...

PDS Biotechnology (PDSB) announced details of a sub-analysis of the cohort of patients with low PD-L1 expression, or CPS 1-19, from the final data ...

Explore the 10 most bizarre and innovative concept cars from Mercedes-Benz, pushing the boundaries of automotive design and technology.

A new report from America’s Health Rankings found that 8.8% adults in Indiana have previously been diagnosed with cancer, and ...

It can be hard to keep track of all the information you get about your cancer diagnosis and treatment. But keeping everything ...